Published in Acta Derm Venereol on January 01, 2008
Multicentre consensus recommendations for skin care in inherited epidermolysis bullosa. Orphanet J Rare Dis (2014) 1.05
Quality of life in patients with bullous dermatoses. Clin Dermatol (2011) 0.93
Prevalence and characterization of pruritus in epidermolysis bullosa. Pediatr Dermatol (2014) 0.82
Pain care for patients with epidermolysis bullosa: best care practice guidelines. BMC Med (2014) 0.77
Peripheral neuro-immune pathology in recessive dystrophic epidermolysis bullosa. J Invest Dermatol (2014) 0.76
Quality of Life and Economic Burden in Recessive Dystrophic Epidermolysis Bullosa. Ann Dermatol (2016) 0.75
Novel and emerging therapies in the treatment of recessive dystrophic epidermolysis bullosa. Intractable Rare Dis Res (2017) 0.75
Oral Manifestations and Dental Management of Epidermolysis Bullosa Simplex. Int J Clin Pediatr Dent (2015) 0.75
Recessive dystrophic epidermolysis bullosa results in painful small fibre neuropathy. Brain (2017) 0.75
A Cross Sectional, Observational Survey to Assess Levels and Predictors of Psychological Wellbeing in Adults with Epidermolysis Bullosa. Health Psychol Res (2013) 0.75
Raising Awareness Among Healthcare Providers about Epidermolysis Bullosa and Advancing Toward a Cure. J Clin Aesthet Dermatol (2017) 0.75
The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol (2008) 3.72
Bullous pemphigoid as pruritus in the elderly: a common presentation. JAMA Dermatol (2013) 2.61
Physical and rehabilitation medicine and self-management education: a comparative analysis of two approaches. J Rehabil Med (2010) 1.94
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus. J Am Acad Dermatol (2008) 1.81
The international dystrophic epidermolysis bullosa patient registry: an online database of dystrophic epidermolysis bullosa patients and their COL7A1 mutations. Hum Mutat (2011) 1.65
Trichostasis spinulosa: itchy follicular papules in young adults. Int J Dermatol (2002) 1.51
IgA-mediated epidermolysis bullosa acquisita: two cases and review of the literature. J Am Acad Dermatol (2002) 1.50
Increased expression of integrin α6β4 in the basement membrane zone lining the sebaceous glands in hidradenitis suppurativa. Acta Derm Venereol (2015) 1.47
Natural gene therapy may occur in all patients with generalized non-Herlitz junctional epidermolysis bullosa with COL17A1 mutations. J Invest Dermatol (2012) 1.45
Keratin 14-null cells as a model to test the efficacy of gene therapy approaches in epithelial cells. J Invest Dermatol (2011) 1.44
Risk of squamous cell carcinoma in junctional epidermolysis bullosa, non-Herlitz type: report of 7 cases and a review of the literature. J Am Acad Dermatol (2011) 1.43
Dexamethasone pulse therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis. Acta Derm Venereol (2007) 1.39
Pigmentation and melanocyte supply to the epidermis depend on type XVII collagen. Exp Dermatol (2014) 1.39
The histopathological spectrum of acute generalized exanthematous pustulosis (AGEP) and its differentiation from generalized pustular psoriasis. J Cutan Pathol (2010) 1.36
Revertant mosaicism in junctional epidermolysis bullosa due to multiple correcting second-site mutations in LAMB3. J Clin Invest (2007) 1.17
Enamel defects in carriers of a novel LAMA3 mutation underlying epidermolysis bullosa. Acta Derm Venereol (2012) 1.11
Retrospective diagnosis of fatal BP180-deficient non-Herlitz junctional epidermolysis bullosa suggested by immunofluorescence (IF) antigen-mapping of parental carriers bearing enamel defects. J Invest Dermatol (2007) 1.10
Functional outcome at school age of preterm infants with periventricular hemorrhagic infarction. Pediatrics (2009) 1.09
Punctate pemphigus: an underreported direct immunofluorescence pattern. J Cutan Pathol (2014) 1.09
Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts. J Am Acad Dermatol (2011) 1.04
Abundance of the long pentraxin PTX3 at sites of leukocytoclastic lesions in patients with small-vessel vasculitis. Arthritis Rheum (2006) 1.03
Revertant mosaicism--patchwork in the skin. N Engl J Med (2009) 1.03
Multiple correcting COL17A1 mutations in patients with revertant mosaicism of epidermolysis bullosa. Am J Hum Genet (2005) 1.02
Basement membrane reconstruction in human skin equivalents is regulated by fibroblasts and/or exogenously activated keratinocytes. J Invest Dermatol (2005) 1.00
Risk factors for adverse outcome in preterm infants with periventricular hemorrhagic infarction. Pediatrics (2008) 0.98
Skin problems of the stump in lower limb amputees: 1. A clinical study. Acta Derm Venereol (2011) 0.98
Partial revertant mosaicism of keratin 14 in a patient with recessive epidermolysis bullosa simplex. J Invest Dermatol (2002) 0.96
Deficiency of ATP2C1, a Golgi ion pump, induces secretory pathway defects in endoplasmic reticulum (ER)-associated degradation and sensitivity to ER stress. J Biol Chem (2004) 0.96
Type XVII collagen regulates lamellipod stability, cell motility, and signaling to Rac1 by targeting bullous pemphigoid antigen 1e to alpha6beta4 integrin. J Biol Chem (2011) 0.93
Is disturbed clearance of apoptotic keratinocytes responsible for UVB-induced inflammatory skin lesions in systemic lupus erythematosus? Arthritis Res Ther (2006) 0.93
Genetic identification and functional validation of FcγRIV as key molecule in autoantibody-induced tissue injury. J Pathol (2012) 0.91
Staphylococcal scalded skin syndrome: loss of desmoglein 1 in patient skin. Eur J Dermatol (2010) 0.91
Skin and heart: une liaison dangereuse. Exp Dermatol (2009) 0.90
LEARN 2 MOVE 0-2 years: effects of a new intervention program in infants at very high risk for cerebral palsy; a randomized controlled trial. BMC Pediatr (2010) 0.90
Revertant mosaicism in heritable skin diseases: mechanisms of natural gene therapy. Discov Med (2012) 0.90
Sensitive and specific assays for routine serological diagnosis of epidermolysis bullosa acquisita. J Am Acad Dermatol (2012) 0.89
Revertant mosaicism due to a second-site mutation in COL7A1 in a patient with recessive dystrophic epidermolysis bullosa. J Invest Dermatol (2010) 0.89
High genetic diversity of Staphylococcus aureus strains colonizing patients with epidermolysis bullosa. Exp Dermatol (2012) 0.89
High anti-staphylococcal antibody titers in patients with epidermolysis bullosa relate to long-term colonization with alternating types of Staphylococcus aureus. J Invest Dermatol (2012) 0.88
Enhanced diagnostic immunofluorescence using biopsies transported in saline. BMC Dermatol (2004) 0.88
PLEC1 mutations underlie adult-onset dilated cardiomyopathy in epidermolysis bullosa simplex with muscular dystrophy. J Invest Dermatol (2009) 0.87
Recombinant IL-6 treatment protects mice from organ specific autoimmune disease by IL-6 classical signalling-dependent IL-1ra induction. J Autoimmun (2012) 0.87
Skin problems of the stump in lower-limb amputees: 2. Influence on functioning in daily life. Acta Derm Venereol (2011) 0.86
Immunoadsorption against two distinct epitopes on human type XVII collagen abolishes dermal-epidermal separation induced in vitro by autoantibodies from pemphigoid gestationis patients. Eur J Immunol (2006) 0.85
Cognitive treatment of illness perceptions in patients with chronic low back pain: a randomized controlled trial. Phys Ther (2012) 0.85
Revertant mosaicism in a human skin fragility disorder results from slipped mispairing and mitotic recombination. J Clin Invest (2012) 0.85
Skin problems in lower limb amputees: a systematic review. Disabil Rehabil (2006) 0.85
Natural gene therapy in dystrophic epidermolysis bullosa. Arch Dermatol (2011) 0.85
Handwriting, visuomotor integration, and neurological condition at school age. Dev Med Child Neurol (2010) 0.84
Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial. Arch Dermatol (2006) 0.83
Transition of pemphigus vulgaris into pemphigus foliaceus confirmed by antidesmoglein ELISA profile. Int J Dermatol (2002) 0.83
Determinants of skin problems of the stump in lower-limb amputees. Arch Phys Med Rehabil (2009) 0.83
Experimental human cell and tissue models of pemphigus. Dermatol Res Pract (2010) 0.83
The main problems of parents of a child with epidermolysis bullosa. Qual Health Res (2008) 0.83
Pigmentary mosaicism following the lines of Blaschko in a girl with a double aneuploidy mosaicism: (47,XX,+7/45,X). Am J Med Genet A (2005) 0.82
First symposium on natural gene therapy of the skin. Exp Dermatol (2012) 0.82
Topography of distinct Staphylococcus aureus types in chronic wounds of patients with epidermolysis bullosa. PLoS One (2013) 0.81
Lethal acantholytic epidermolysis bullosa. Dermatol Clin (2010) 0.81
Neural correlates of developmental coordination disorder. Dev Med Child Neurol (2013) 0.81
The inversa type of recessive dystrophic epidermolysis bullosa is caused by specific arginine and glycine substitutions in type VII collagen. J Med Genet (2010) 0.80
Benefits of treatment theory in the design of explanatory trials: cognitive treatment of illness perception in chronic low back pain rehabilitation as an illustrative example. J Rehabil Med (2010) 0.80
Blistering disease: insight from the hemidesmosome and other components of the dermal-epidermal junction. Cell Tissue Res (2014) 0.80
GMFM in infancy: age-specific limitations and adaptations. Pediatr Phys Ther (2013) 0.80
Hereditary multiple cutaneous leiomyoma resulting from novel mutations in the fumarate hydratase gene. J Dermatol Sci (2008) 0.79
Improving rehabilitation treatment in a local setting: a case study of prosthetic rehabilitation. Clin Rehabil (2009) 0.79
Mutation analysis of the entire keratin 5 and 14 genes in patients with epidermolysis bullosa simplex and identification of novel mutations. Hum Mutat (2003) 0.79
Functional performance, participation and autonomy after discharge from prosthetic rehabilitation: barriers, facilitators and outcomes. J Rehabil Med (2014) 0.79
The IgG "lupus-band" deposition pattern of pemphigus erythematosus: association with the desmoglein 1 ectodomain as revealed by 3 cases. Arch Dermatol (2012) 0.78
Clouston syndrome can mimic pachyonychia congenita. J Invest Dermatol (2003) 0.78
Two major 5'-untranslated regions for type XVII collagen mRNA. J Dermatol Sci (2006) 0.78
Extensive acantholysis as the major histological feature of a severe case of Dowling Meara-epidermolysis bullosa simplex: a reappraisal of acantholysis in the newborn. Eur J Dermatol (2012) 0.78
Health-related physical fitness in Dutch children with developmental coordination disorder. J Dev Behav Pediatr (2012) 0.78
Surgical treatment of sinuses by deroofing in hidradenitis suppurativa. Dermatol Surg (2011) 0.78
Letter regarding the article: "R298Q mutation of p63 gene in autosomal dominant ectodermal dysplasia associated with arrhythmogenic right ventricular cardiomyopathy" by Valenzise et al. Eur J Med Genet (2009) 0.78
Epidermolysis bullosa in the Netherlands. Dermatol Clin (2010) 0.77
Risk factors for emergence and progression of scoliosis in children with severe cerebral palsy: a systematic review. Dev Med Child Neurol (2010) 0.77
Limited motor performance and minor neurological dysfunction at school age. Acta Paediatr (2010) 0.77
Health-related quality of life in epidermolysis bullosa: Validation of the Dutch QOLEB questionnaire and assessment in the Dutch population. Acta Derm Venereol (2014) 0.77
Use and functioning of the affected limb in children with unilateral congenital below-elbow deficiency during infancy and preschool age: a longitudinal observational multiple case study. Early Hum Dev (2012) 0.77
A systematic evaluation of the effect of thumb opponens splints on hand function in children with unilateral spastic cerebral palsy. Clin Rehabil (2011) 0.77
Insights from a desmoplakin mutation identified in lethal acantholytic epidermolysis bullosa. J Invest Dermatol (2010) 0.77
Long-term follow-up of patients with recessive dystrophic epidermolysis bullosa in the Netherlands: expansion of the mutation database and unusual phenotype-genotype correlations. J Dermatol Sci (2009) 0.77
Dexamethasone pharmacokinetics after high-dose oral therapy for pemphigus. Ann Pharmacother (2002) 0.76
Novel TGM5 mutations in acral peeling skin syndrome. Exp Dermatol (2015) 0.76
The benefits of theory for clinical practice: cognitive treatment for chronic low back pain patients as an illustrative example. Disabil Rehabil (2008) 0.76
Interdisciplinary management of epidermolysis bullosa in the public setting: the Netherlands as a model of care. Dermatol Clin (2010) 0.76
Neural correlates of paediatric dysgraphia. Dev Med Child Neurol (2013) 0.75
U- versus n-serrated immunofluorescence pattern distinguishes EBA from BP. Letter to the editor regarding "linear arrangement of neutrophils along the basal layer in bullous pemphigoid: a unique histological finding". Am J Dermatopathol (2014) 0.75
Dexamethasone pulse therapy: evidence for no benefit in pemphigus. Indian J Dermatol Venereol Leprol (2011) 0.75
Punch grafting of chronic ulcers in patients with laminin-332-deficient, non-Herlitz junctional epidermolysis bullosa. J Am Acad Dermatol (2012) 0.75
A simple and effective approach to pemphigus. Indian J Med Sci (2007) 0.75
On making a difference: the case of self-management education and physical and rehabilitation medicine. J Rehabil Med (2011) 0.75
Differential IgG recognition of desmoglein 3 by paraneoplastic pemphigus and pemphigus vulgaris sera. J Invest Dermatol (2012) 0.75
[Acute skin detachment in a newborn]. Ned Tijdschr Geneeskd (2013) 0.75
Analysis of cutaneous somatic mosaicism. Methods Mol Biol (2013) 0.75